Showing 18,101 - 18,120 results of 18,609 for search 'significantly ((((((lower decrease) OR (linear decrease))) OR (a decrease))) OR (greater decrease))', query time: 0.45s Refine Results
  1. 18101

    Table 3_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.docx by Ömer Bektaş (13827139)

    Published 2025
    “…</p>Results<p>Patients treated before 12 months of age showed the most significant improvements in motor milestones, with 58.7% of Cohort A achieving independent sitting. …”
  2. 18102

    Table 5_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.docx by Ömer Bektaş (13827139)

    Published 2025
    “…</p>Results<p>Patients treated before 12 months of age showed the most significant improvements in motor milestones, with 58.7% of Cohort A achieving independent sitting. …”
  3. 18103

    Table 4_Isowighteone attenuates vascular calcification by targeting HSP90AA1-mediated PI3K-Akt pathway and suppressing osteogenic gene expression.xls by Yuanxi Mo (22090130)

    Published 2025
    “…(F. hispida, Moraceae), has demonstrated significant anti-inflammatory properties in prior studies. …”
  4. 18104

    Data Sheet 1_Real-world analysis of leuprorelin acetate microspheres-based neoadjuvant therapy for patients with high-risk prostate cancer.docx by Changde Fu (20899748)

    Published 2025
    “…</p>Results<p>The median prostate-specific antigen (PSA) was 34.1 ng/mL before neoadjuvant therapy and reduced to 0.8 ng/mL after neoadjuvant therapy (P<0.001). Testosterone showed a decreased tendency after neoadjuvant therapy, but without statistical significance (P=0.185). …”
  5. 18105
  6. 18106

    Revisiting the association between sodium-glucose cotransporter-2 inhibitors and the risk of neoplasm in patients with type 2 diabetes: new insights from an updated systematic revi... by Yiran Wang (1492303)

    Published 2025
    “…</p> <p>Type 2 diabetes (T2D) is a chronic metabolic disease that affects 1 in 10 people worldwide, and cancer is now recognized as a common and severe complication of T2D. …”
  7. 18107

    USUV replicates in STAT1-sufficient peripheral tissues leading to spleen and liver pathology. by Amy N. Nelson (21763146)

    Published 2025
    “…<b>(G)</b> H&E staining of spleen tissue collected from mock or USUV-infected mice with a 200 µm scale bar. Decreased red pulp due to massive immune cell infiltration was observed in Vav-Cre/<i>Stat1</i><sup>fl/fl</sup> and <i>Stat1</i><sup>-/-</sup> mice. …”
  8. 18108

    CDCP1 regulates CDA and hENT1 expression through c-Src/PKCδ signaling pathway. by Kun-Lin Hsieh (11401919)

    Published 2025
    “…<p>(A, B) Quantitative PCR analysis of CDA and hENT1 mRNA expression levels in T24, T24-CD, and T24-CDKO cells. …”
  9. 18109

    Table 9_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

    Published 2024
    “…The primary aims of this study were to estimate anti-Histoplasma antibody seroprevalence in the equid population in rural The Gambia and to explore risk factors for seropositivity.</p>Methods<p>A nationwide cross-sectional study was conducted (February–July 2022), representing baseline measurements of a longitudinal cohort study. …”
  10. 18110

    Table 1_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

    Published 2024
    “…The primary aims of this study were to estimate anti-Histoplasma antibody seroprevalence in the equid population in rural The Gambia and to explore risk factors for seropositivity.</p>Methods<p>A nationwide cross-sectional study was conducted (February–July 2022), representing baseline measurements of a longitudinal cohort study. …”
  11. 18111

    Table 2_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

    Published 2024
    “…The primary aims of this study were to estimate anti-Histoplasma antibody seroprevalence in the equid population in rural The Gambia and to explore risk factors for seropositivity.</p>Methods<p>A nationwide cross-sectional study was conducted (February–July 2022), representing baseline measurements of a longitudinal cohort study. …”
  12. 18112

    Table 10_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

    Published 2024
    “…The primary aims of this study were to estimate anti-Histoplasma antibody seroprevalence in the equid population in rural The Gambia and to explore risk factors for seropositivity.</p>Methods<p>A nationwide cross-sectional study was conducted (February–July 2022), representing baseline measurements of a longitudinal cohort study. …”
  13. 18113

    Table 3_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

    Published 2024
    “…The primary aims of this study were to estimate anti-Histoplasma antibody seroprevalence in the equid population in rural The Gambia and to explore risk factors for seropositivity.</p>Methods<p>A nationwide cross-sectional study was conducted (February–July 2022), representing baseline measurements of a longitudinal cohort study. …”
  14. 18114

    Table 8_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

    Published 2024
    “…The primary aims of this study were to estimate anti-Histoplasma antibody seroprevalence in the equid population in rural The Gambia and to explore risk factors for seropositivity.</p>Methods<p>A nationwide cross-sectional study was conducted (February–July 2022), representing baseline measurements of a longitudinal cohort study. …”
  15. 18115

    Table 6_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

    Published 2024
    “…The primary aims of this study were to estimate anti-Histoplasma antibody seroprevalence in the equid population in rural The Gambia and to explore risk factors for seropositivity.</p>Methods<p>A nationwide cross-sectional study was conducted (February–July 2022), representing baseline measurements of a longitudinal cohort study. …”
  16. 18116

    Table 5_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

    Published 2024
    “…The primary aims of this study were to estimate anti-Histoplasma antibody seroprevalence in the equid population in rural The Gambia and to explore risk factors for seropositivity.</p>Methods<p>A nationwide cross-sectional study was conducted (February–July 2022), representing baseline measurements of a longitudinal cohort study. …”
  17. 18117

    Table 4_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

    Published 2024
    “…The primary aims of this study were to estimate anti-Histoplasma antibody seroprevalence in the equid population in rural The Gambia and to explore risk factors for seropositivity.</p>Methods<p>A nationwide cross-sectional study was conducted (February–July 2022), representing baseline measurements of a longitudinal cohort study. …”
  18. 18118

    Table 7_Exploring Histoplasma species seroprevalence and risk factors for seropositivity in The Gambia’s working equid population: Baseline analysis of the Tackling Histoplasmosis... by Tessa Rose Cornell (15460726)

    Published 2024
    “…The primary aims of this study were to estimate anti-Histoplasma antibody seroprevalence in the equid population in rural The Gambia and to explore risk factors for seropositivity.</p>Methods<p>A nationwide cross-sectional study was conducted (February–July 2022), representing baseline measurements of a longitudinal cohort study. …”
  19. 18119

    Table 4_Analysis of global trends in acute lymphoblastic leukemia in children aged 0–5 years from 1990 to 2021.docx by Fang Ding (222713)

    Published 2025
    “…Background<p>Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, with a significant global burden. This study evaluates global, regional, and national trends in the prevalence, mortality, and disability-adjusted life years (DALYs) of childhood ALL from 1990 to 2021, providing insights into disparities and progress across different socio-demographic and geographic contexts.…”
  20. 18120

    DataSheet1_CircFOXO3 upregulation mediates the radioresistance of glioblastoma by affecting cellular metabolome.DOCX by Hao Xu (6530)

    Published 2024
    “…Introduction<p>Radioresistance remains a significant challenge in the treatment of glioblastoma multiforme (GBM), the most prevalent and lethal brain cancer in adults. …”